Skip to content

Clinical effectiveness of Ninjin'yoeito in Patients with Chronic Respiratory Diseases

Clinical effectiveness of Ninjin'yoeito in Patients with Chronic Respiratory Diseases - Clinical effectiveness of Ninjin'yoeito in Patients with Chronic Respiratory Diseases

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046367
Enrollment
100
Registered
2021-12-13
Start date
2021-12-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Respiratory Diseases

Interventions

yoeito Untreated

Sponsors

Kindai Universuty
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with chronic respiratory diseases (e.g. COPD and NTM)

Exclusion criteria

Exclusion criteria: 1) Under 20 years old 2) Pregnant women 3) Patients with concomitant diseases with poor prognosis (e.g., end-stage cancer, severe heart failure, liver cirrhosis, etc.)

Design outcomes

Primary

MeasureTime frame
Body weight, fluid composition, blood biochemistry (TP, Alb, ChE) after 6 months of administration of Ninjin'yoeito

Secondary

MeasureTime frame
Grip strength, walking speed, questionnaire (frailty checklist)

Countries

Japan

Contacts

Public ContactMasato Muraki

Kindai Universuty Nara Hospital Department of Respiratory Medicine and Allergology

muraki-m@med.kindai.ac.jp0743-77-0880

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026